Deep Knowledge Group and Sharjah Research, Technology and Innovation Park launch the Life Sciences in the UAE report
Deep Knowledge Group (DKG) and the Sharjah Research, Technology and Innovation Park (SRTIP) have recently co-hosted a TechTalk to reveal their jointly-produced Life Sciences in the UAE report.
The event saw Anastasia Lit, Director of Investor Relations, Europe & MENA, Deep Knowledge Group discuss key developments in the Life Sciences industry, highlighting the emerging Longevity Industry and its focus on healthy ageing.
Building a sustainable future through FoodTech
"Building a Sustainable Future Through FoodTech" is our next highly anticipated virtual event. We will review today’s FoodTech landscape and its practical application of innovations for sustainable sourcing, production and distribution of food.
This event will bring together world renowned founders, innovators, thoughtleaders, startups and companies disrupting the FoodTech Sector for social good. From accomplished speakers presenting their best sustainable tech, to a live panel and Q&A, join us for an interactive and thought provoking event to really delve into the latest trends building a sustainable future through FoodTech.
Health is the new wealth
Since the beginning of time, humans have been keen on living healthier, wealthier and longer lives. The Longevity industry is built on this principle.
This event is co-hosted with the Sharjah Research, Technology and Innovation Park to provide a comprehensive overview of the impact of investing in longevity, its overall relevance, and the landscape of longevity industries.
Date: April 20, 2022
Time: 8:30 PM UAE time
Location: Sharjah Research, Technology and Innovation Park (https://goo.gl/maps/8XSMzwd589RZL3jEA)
The Emerging Longevity Industry: A UAE Perspective
To refine and elevate the discourse on Longevity (healthy ageing), DKG conducted an online event, The Emerging Longevity Industry — A UAE Perspective, in association with Sharjah Research Technology & Innovation Park (SRTIP) on Feb. 14, 2022. In the UAE, the Longevity sector is expected to hit $23 billion in 2026, growing at a CAGR of 3%.
This event was graced by some of the well-known personalities of the UAE, including H.E. Dr Amin Al Amiri, Undersecretary for the Health Regulation Sector at UAE Ministry of Health and H.E. Hussain AlMahmoudi, CEO of Sharjah Research, Technology and Innovation Park (SRTIP).
The Rise of Advanced Technologies in the Pharmaceutical Industry
On November 15th - 17th 2021 Deep Pharma Intelligence (DPI) hosted three virtual events that will focus on key industry trends, activities, and investing takeaways in the artificial intelligence (AI) in the Pharma sector. DPI is an outstanding provider of open source and proprietary analytics in the Pharmaceutical and AI in Pharma industry, and a joint venture formed between Deep Knowledge Group’s DeepTech-focused analytical subsidiary, Deep Knowledge Analytics, and Biopharma Trend.
A growing number of industry experts were presented and discussed the increasing market maturation of the AI in Pharma space, from both a collaborative effort and alliance perspective, as well as financing, agreement, M&A, SPAC and IPO perspective at the conference "The Rise of Advanced Technologies in the Pharmaceutical Industry".
The Technology Revolution of FoodTech Indusrty
On "The Technology Revolution of FoodTech Industry" webinar influencers and main experts of the FoodTech industry shared their insights and researches on emerging trends and application of modern technologies in the industry.
The event featured a summary of key players, technologies and trends, including R&D and business aspects, as well as investment trends.
During this open-access event, global experts of the FoodTech industry discussed new horizons of the market.
FoodTech is the emergent sector exploring how technology can be leveraged to improve efficiency and sustainability in designing, producing, choosing, delivering and consumption of food. The FoodTech Industry is developing rapidly and includes more than 5,000 startups globally.
PRESS LAUNCH: Blockchain Industry in the UK Landscape Overview
Wed, Nov 3, 2021; 10-11 AM (GMT)
Big Innovation Centre, Greengage and Deep Knowledge Analytics invited to the online Press Launch of the major analysis and report, ‘Blockchain Industry in the UK Landscape Overview 2021′. It is a new version of our 2018 analysis and report originally published in dialogue with the All-Party Parliamentary Group on Blockchain (APPG Blockchain) which contained the first comprehensive mapping of the UK Blockchain landscape.
The 2021 analysis and report identify and profile 520 true Blockchain-centric companies across 18 blockchain sectors and 50 cities in the UK. These sectors include fintech, crypto-trading, energy, art and more. The 2021 UK Blockchain landscape overview in particular breaks down on a company-by-company basis more than £1,6 billion worth of investments into UK blockchain companies. Additionally, it profiles hundreds of UK’s blockchain experts across industry, academia, and policy.
GovTech Development During COVID-19: How Technologies Have Helped
‘GovTech Development During COVID-19: How Technologies Have Helped’ is a conference dedicated to coverage of the most effective E-government and GovTech solutions, implemented during the COVID-19 period. The scope of the conference split into five main directions that are - Government Efficiency, Economy Resilience, Healthcare Management, Quarantine Efficiency, and Vaccination Rate.
The event brought together policy-makers, government officials and field experts all over the world to share their experiences and insights learnt from the pandemic. Also, the expansion of E-government and GovTech tools usage was considered for the Post-pandemic world. Lastly, the further course of the global fight against coronavirus and the necessary steps we have taken to consideration at this point was discussed.
AI Driven Drug Repositioning and Repurposing Summit 2021
Tue, Apr 20, 2021 — Wed, Apr 21, 2021
The AI Driven Drug Repositioning & Repurposing Summit brought together 80+ leaders in repurposing and pioneers in AI and machine learning to strategize how repurposing can reach its full potential to:
• Improve time and cost savings of drug development
• Leverage the safety advantage in reducing development risk
• Unlock market potential advantage
• Improve return on investment for repurposed drugs
• Explore out-licensing options
This meeting aims to help Pharma, BioTech and academics stay ahead of the curve in their repurposing endeavours during a period exploding with new technologies. The was a cutting-edge discussion with the likes of AstraZeneca, BenevolentAI, and Healx, to solve ongoing technical challenges surrounding AI tools in repurposing, understand the delicate risk-reward balance in potential repurposing opportunities and explore lessons learned from AI applications in repurposing during Covid-19.
4th Annual AI-ML Drug Discovery Summit 2021
The AI-ML: Drug Discovery Summit is the industry’s definitive guide to translating the wealth of tech available to successfully implement a working and practically effective drug discovery and development platform.
Designed with leading AI experts from R&D and clinical departments across Bid Pharma, BioTech, and Academia, the forum featured 3 days of real-world case studies and interactive discussions. As such, the 2021 AI-ML Summit provided a roadmap to augmented R&D and clinical decision making with reduced failure rates, increased speed, and improved margins.
This is a critical time for drug developers to make more data-driven decisions, and the 4th AI-ML: Drug Discovery Summit showed how to strategically leverage AI technology to transform your pipelines, and patients’ lives.
Tue, Jan 26, 2021 — Thu, Jan 28, 2021
Building on the success in 2019, the 2nd Longevity Therapeutics 2020 Summit once again returned to San Francisco. As the only industry-led and end-to-end longevity meeting, we heard success stories in the last 12 months and explored what’s next to help you accelerate your pipeline into the clinic! Uniting BioTech drug developers, academics, investors and pharma companies endeavouring to develop innovative anti-aging drugs and overcome key preclinical, translational, clinical and regulatory challenges going forward.
2nd Longevity Therapeutics 2020 Summit
Tue, Jan 28, 2020 — Thu, Jan 30, 2020
San Francisco CA, USA
3rd Annual AI-ML Drug Discovery & Development Summit
The 3rd Annual AI-ML: Drug Discovery & Development Summit is the industry’s definitive guide to translating the wealth of tech available to successful, efficacious and efficient R&D processes. With 3 days of real-world case studies, this summit provided the roadmap to augmented R&D decision making with reduced failure rates, increased speed and improved margins.
This year’s summit took a deeper look at:
Target, pathway and molecule selection – identifying which will treat individual disease indications better
Predictive preclinical models – knowing from the beginning how drug candidates will react when administered to in vivo and in vitro models
Identification of the patients who will react best to the treatment with minimal side effects for a guaranteed successful clinical trial.
DoubleTree by Hilton Hotel San Diego, United States
Mon, Feb 24, 2020 — Wed, Feb 26, 2020
Mon, Nov 11, 2019 07:45 AM — Tue, Nov 12, 2019 12:45 AM
AI Applications in Biopharma Summit
The AI Applications in Biopharma Summit is the only event to convene key strategic biopharma stakeholders and data driven disruptors to discuss their experiences, obstacles, opportunities for partnerships, and strategies they have used to implement AI technologies in the discovery and drug development process. According to them, a broker like Libertex is a better choice for trading because of its higher chance of successful trading.
Interest in AI driven technologies is growing fast among leaders in the biopharma industry. Over 40 industry peers discussed the practical steps for prioritizing and implementing AI technologies to achieve the greatest impact and ROI. The event enabled industry leaders to find partners to help keep the AI in Biopharma movement growing and moving forward.